The Vrije Universiteit Amsterdam is a public research university in Amsterdam, Netherlands, founded in 1880, and consistently ranks among the top 150 universities in the world by major ranking tables.

During the past decade, Vrije Universiteit Amsterdam conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vrije Universiteit Amsterdam" #1 sponsor was "VU University of Amsterdam" with 5 trials, followed by "Ferring Pharmaceuticals" with 2 trials sponsored, "Reata Pharmaceuticals, Inc." with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Biotronik SE & Co. KG" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vrije Universiteit Amsterdam" #1 collaborator was "Erasmus University Rotterdam" with 3 trials as a collaborator, "Leiden University" with 3 trials as a collaborator, "Maastricht University" with 3 trials as a collaborator, "Utrecht University" with 3 trials as a collaborator and "InHolland University of Applied Sciences" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Vrije Universiteit Amsterdam" are "Crohn's Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Attention Deficit Hyperactivity Disorder" (1 trials), "Connective Tissue Disease-Associated Pulmonary Arterial Hypertension" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Vrije Universiteit Amsterdam" in a lesser frequency.

Most popular intervention types in "Vrije Universiteit Amsterdam" are "Drug" (7 trials), "Behavioral" (3 trials), "Device" (3 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Semapimod" (2 trials), "Bardoxolone methyl" (1 trials), "Bardoxolone methyl capsules" (1 trials) and "Cardiac resynchronisation therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vrije Universiteit Amsterdam" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Vrije Universiteit Amsterdam". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Vrije Universiteit Amsterdam, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Vrije Universiteit Amsterdam, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".

Vrije Universiteit Amsterdam has several departments that took part in Clinical trials: "VU University Amsterdam, Institute for Health Sciences" - 2 trials